ENTAMOEBA SP - ANVISA Registration 80254180250
Access comprehensive regulatory information for ENTAMOEBA SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180250 and manufactured by REMEL EUROPE LIMITED. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, ACRO BIOTECH, INC. (MONTCLAIR), and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80254180250
25351151390201704
04930429000139
Company Information
Dates and Status
Apr 24, 2017
VIGENTE
09/18/2025 19:00:01
R-BIOPHARM AGโข Germany
ACRO BIOTECH, INC. (MONTCLAIR)โข United States of America
HYSEN BIOTECH.LNCโข South Korea
KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDAโข Brazil
ACRO BIOTECH, INCโข United States of America
ENTAMOEBA SP
Entamoeba Histolytica Rapid Test Cassette
HYSEN BIOTECH.LNC
80464810922
Jun 16, 2025
ENTAMOEBA SP
RIDASCREENยฎ Entamoeba
R-BIOPHARM AG
82890930008
Apr 28, 2025
ENTAMOEBA SP
E. histolytica TF Quicktest
BIO BRASIL CIENCIA E TECNOLOGIA LTDA
81249610020
Jan 15, 2024
ENTAMOEBA SP
Famรญlia Cassete de Teste Rรกpido de Entamoeba histolytica (Fezes)
HANGZHOU ALLTEST BIOTECH CO., LTD
81325990289
Jul 31, 2023
ENTAMOEBA SP
FASTLINE ENTAMOEBA HISTOLYTICA Ag
KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA
80105220121
Mar 13, 2023

